Tomasz Janicki - Burzynski Research Vice President - Clinical Trials

BZYR Stock  USD 0.04  0.01  20.00%   

President

Dr. Tomasz Janicki, M.D., serves as Vice President Clinical Trials of the Company, since March 1, 2012. Dr. Janicki currently works at Burzynski Clinic. Dr. Janicki joined Burzynski Clinic in 1997 as Research Associate and has served as Director of Medical Documentation at Burzynski Clinic since 2002. Dr. Janicki was involved in the administrative oversight of the Research Department at Burzynski Clinic, and has coauthored 43 publications and presentations for the advancement and acceleration of research and clinical trials at Burzynski Clinic. Dr. Janicki received his M.D. degree from Medical University in Wroclaw, Poland. since 2012.
Age 47
Tenure 12 years
Phone713 335 5697
Webhttps://www.burzynskiclinic.com

Burzynski Research Management Efficiency

The company has return on total asset (ROA) of (127.6631) % which means that it has lost $127.6631 on every $100 spent on assets. This is way below average. Burzynski Research's management efficiency ratios could be used to measure how well Burzynski Research manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

PRESIDENT Age

Amy RockCumberland Pharmaceuticals
N/A
Yuichi TsujimotoHUTCHMED DRC
60
John DerenTeleflex Incorporated
N/A
Morio SumiyaHUTCHMED DRC
55
Koji SumiokaHUTCHMED DRC
59
Hiroshi TokushigeHUTCHMED DRC
64
Steve HightowerPresidio Property Trust
56
Karen BoylanTeleflex Incorporated
47
James FergusonTeleflex Incorporated
N/A
Matthew JamesTeleflex Incorporated
N/A
Cameron HicksTeleflex Incorporated
59
Roger GrahamTeleflex Incorporated
N/A
Thomas PowellTeleflex Incorporated
62
James LeydenTeleflex Incorporated
52
Mario WijkerTeleflex Incorporated
52
Leo PavlivCumberland Pharmaceuticals
54
Tadashi MotoiHUTCHMED DRC
56
Praneet MehrotraTeleflex Incorporated
N/A
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States. Burzynski Research [BZYR] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Burzynski Research Leadership Team

Elected by the shareholders, the Burzynski Research's board of directors comprises two types of representatives: Burzynski Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Burzynski. The board's role is to monitor Burzynski Research's management team and ensure that shareholders' interests are well served. Burzynski Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Burzynski Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
Patryk Goscianski, Treasurer, Secretary
Tomasz Janicki, Vice President - Clinical Trials
Barbara Burzynski, Director
Carlton Hazlewood, Director
Gregory Burzynski, Director
Stanislaw Burzynski, Chairman of the Board and Presidentident

Burzynski Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Burzynski Research a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Burzynski Research in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Burzynski Research's short interest history, or implied volatility extrapolated from Burzynski Research options trading.

Pair Trading with Burzynski Research

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burzynski Research position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burzynski Research will appreciate offsetting losses from the drop in the long position's value.

Moving together with Burzynski Pink Sheet

  0.72BA Boeing Fiscal Quarter End 31st of March 2024 PairCorr

Moving against Burzynski Pink Sheet

  0.81AXP American Express Sell-off TrendPairCorr
  0.81IBM International Business Fiscal Quarter End 31st of March 2024 PairCorr
  0.79DIS Walt Disney Aggressive PushPairCorr
  0.78TRV The Travelers Companies Fiscal Quarter End 31st of March 2024 PairCorr
  0.76WMT Walmart Financial Report 16th of May 2024 PairCorr
The ability to find closely correlated positions to Burzynski Research could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burzynski Research when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burzynski Research - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burzynski Research to buy it.
The correlation of Burzynski Research is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burzynski Research moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burzynski Research moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Burzynski Research can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burzynski Research. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Burzynski Pink Sheet analysis

When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stocks Directory
Find actively traded stocks across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Please note, there is a significant difference between Burzynski Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if Burzynski Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Burzynski Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.